BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28701327)

  • 1. Tetanus neurotoxin: conformational plasticity as an adaptive strategy.
    Montal M
    EMBO Rep; 2017 Aug; 18(8):1268-1270. PubMed ID: 28701327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The affinity of the nerve fiber for tetanus toxin.
    ROOFE PG
    J Kans Med Soc; 1948 Feb; 49(2):60. PubMed ID: 18862370
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural analysis of the catalytic domain of tetanus neurotoxin.
    Rao KN; Kumaran D; Binz T; Swaminathan S
    Toxicon; 2005 Jun; 45(7):929-39. PubMed ID: 15904688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutinin.
    Krell T; Greco F; Nicolaï MC; Dubayle J; Renauld-Mongénie G; Poisson N; Bernard I
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):241-51. PubMed ID: 12911336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary X-ray analysis of tetanus neurotoxin C fragment.
    Umland TC; Wingert L; Swaminathan S; Schmidt JJ; Sax M
    Acta Crystallogr D Biol Crystallogr; 1998 Mar; 54(Pt 2):273-5. PubMed ID: 9761892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin type E fragmented with endoproteinase Lys-C reveals the site trypsin nicks and homology with tetanus neurotoxin.
    Giménez JA; DasGupta BR
    Biochimie; 1990 Apr; 72(4):213-7. PubMed ID: 2116911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tetanus neurotoxin-sensitive and insensitive routes to and from the plasma membrane: fast and slow pathways?
    Proux-Gillardeaux V; Rudge R; Galli T
    Traffic; 2005 May; 6(5):366-73. PubMed ID: 15813747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetanus neurotoxin.
    Rossetto O; Scorzeto M; Megighian A; Montecucco C
    Toxicon; 2013 May; 66():59-63. PubMed ID: 23419592
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tetanus neurotoxin-mediated cleavage of cellubrevin impairs epithelial cell migration and integrin-dependent cell adhesion].
    Proux-Gillardeaux V; Galli T
    Med Sci (Paris); 2005 Oct; 21(10):789-90. PubMed ID: 16197886
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular Methods for Identification of Clostridium tetani by Targeting Neurotoxin.
    Nagoba B; Dharne M; Gohil KN
    Methods Mol Biol; 2017; 1600():37-47. PubMed ID: 28478555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active site structure of tetanus neurotoxin resolved by multiple scattering analysis in X-Ray absorption spectroscopy.
    Meneghini C; Morante S
    Biophys J; 1998 Oct; 75(4):1953-63. PubMed ID: 9746536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amino-thiols inhibit the zinc metallopeptidase activity of tetanus toxin light chain.
    Martin L; Cornille F; Coric P; Roques BP; Fournié-Zaluski MC
    J Med Chem; 1998 Aug; 41(18):3450-60. PubMed ID: 9719598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "BINACLE" assay for in vitro detection of active tetanus neurotoxin in toxoids.
    Behrensdorf-Nicol HA; Weisser K; Krämer B
    ALTEX; 2015; 32(2):137-42. PubMed ID: 25769344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
    Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
    Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Recombinant Human scFv Against Tetanus Toxin Heavy Chain by Phage Display Technology.
    Khalili E; Lakzaei M; Rasaee MJ; Aminian M
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):303-9. PubMed ID: 26492617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of tetanus.
    Bleck TP
    Clin Neuropharmacol; 1986; 9(2):103-20. PubMed ID: 3518923
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus.
    Bercsenyi K; Schmieg N; Bryson JB; Wallace M; Caccin P; Golding M; Zanotti G; Greensmith L; Nischt R; Schiavo G
    Science; 2014 Nov; 346(6213):1118-23. PubMed ID: 25430769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetanus neurotoxin HCC protein commits T cells to IFN-γ producing cells.
    Torabi Goudarzi S; Hajivalili M; Hosseini M; Ghafari Khamene M; Yazdani Y; Sadreddini S; Miahipour A; Younesi V; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):20-4. PubMed ID: 27064869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.